SEC Form 4 · accession 0001862147-26-000009
Nuvalent, Inc. · NUVL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexandra Balcom
Officer — Chief Financial Officer
Period of report
Jul 1, 2026
Accepted (ET)
Jul 6, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001861560
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jul 1, 2026 | M | 5,384 | $6.89 | A | 90,917 | D | |
| Class A Common Stock | Jul 1, 2026 | M | 6,046 | $18.93 | A | 96,963 | D | |
| Class A Common StockF2 | Jul 1, 2026 | S | 11,430 | $123.58 | D | 85,533 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $6.89 | Jul 1, 2026 | M | 5,384 | D | — | Apr 29, 2031 | Class A Common Stock | 5,384 | 8,016 | D |
| Stock Option (Right to Buy)F3 | $18.93 | Jul 1, 2026 | M | 6,046 | D | — | Jan 4, 2032 | Class A Common Stock | 6,046 | 22,933 | D |
Explanation of responses
- F1These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2025.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.51 to $123.62, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
- F3The shares underlying this option are fully vested.